Stockreport

Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block F...

Revolution Medicines, Inc.  (RVMD) 
PDF Beyond G12C with Small Molecules and Immuno-Oncology" Session at AACR 2024 in San Diego REDWOOD CITY, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, [Read more]